Pricing Strategy and Profitability Analysis Across Product Lines

Introduction

Previously, strategies were developed for three different products: the X5, X6, and X7. These strategies were based on cost-volume-profit analysis, the product life cycle, and different pricing strategies. This report highlights the results of those strategies and explains why they occurred, drawing on underlying economic theory. The X5 analysis showed that increasing the price would deliver lower sales volume but higher overall profit, a finding that was confirmed for the X6 as well. The X7 presented a different challenge. Elasticity data was initially unavailable, but the product's poor performance at a $195 price point suggested that a lower price could stimulate demand. Accordingly, the strategic approach was to implement targeted pricing for each product based on its position in the lifecycle and its price sensitivity.

The following table illustrates the financial results of these pricing and resource allocation decisions across the strategy period:

The X5: Premium Pricing in Decline

Year-by-Year Profit Performance
2011: $81,571,138
2012: $361,796,857
2013: $849,408,401
2014: $1,372,679,239
2015: $1,612,592,251

The X5 provides a clear validation of cost-volume-profit (CVP) analysis in practice. During 2012 and 2013, the X5 and X6 were in the growth stage of the product life cycle and were the major drivers of profit. The X5 remained profitable throughout its sales period, extending into 2014, exactly as predicted by CVP analysis. The underlying logic is straightforward: when a product has low price elasticity, customers are relatively insensitive to price changes. This means that a higher price reduces the quantity demanded only slightly, while significantly increasing the margin on each unit sold. The net effect is higher total profit.

The X6: Maintaining Profitability at Maturity

By 2014, the final year of X5 sales, the product had reached 93% market saturation, indicating that most potential customers had already purchased. Despite this advanced stage in the lifecycle, the X5 generated a profit of $132,844,724. The product received no R&D investment, yet remained highly profitable—a testament to its established market position and strong consumer demand at the premium price point. The fact that sales volume declined with the higher price was more than offset by the improved margin per unit, allowing the company to extract maximum value from the product before it exited the market entirely.

The X6 followed a similar strategic path, but operated over a longer period that carried it into the maturity stage of the product lifecycle. This stage typically calls for strong product lifecycle management, particularly when supported by R&D investments. Cost-volume-profit analysis indicated that the X6 had low price elasticity, meaning that customers would accept higher prices without dramatically reducing their purchases.

The X7: Low-Price Strategy for Growth

A price increase to $441 had the intended effect. By 2015, the X6 had achieved 92% market saturation and generated a profit of $159,126,896. At this saturation level, the product was approaching end-of-life and was likely to be discontinued in 2016. The strategic objective during maturity was clear: maximize profit extraction before the product declined. By raising the price, the company achieved precisely this outcome. While it reduced the number of units sold, the higher revenue per unit ensured that total profit remained strong right up to the point where the product would no longer cover fixed costs.

The X7 presented a fundamentally different strategic challenge and required a different pricing approach. Initial analysis suggested that lowering the price made sense because demand was poor at the $195 price point. However, the lack of elasticity data created uncertainty. Rather than guess, the team made an aggressive decision: instead of a modest drop to $185, the price was cut to $165 across the entire period, allowing for the collection of real-world elasticity data.

This strategy proved successful. While the X7 initially lost money in 2012 and 2013, it turned profitable after that. By 2015, the X7 earned $80,786,116 in profit and had captured 9% of the market—a dramatic turnaround from its earlier struggles. The elasticity data collected during this period revealed something important: the product would likely benefit from being priced even lower. With fixed costs of only $65 per unit, there is substantial room to reduce price further while maintaining profitability. Price elasticity of demand analysis suggested that further price reductions could unlock even greater market share and profits, making the low-price strategy for this product a foundation for future growth.